Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Dec 29, 2022 6:00pm
237 Views
Post# 35196147

RE:RE:Just the facts …need to be understood

RE:RE:Just the facts …need to be understood

Warmest Regards westcoast. 

A buyout or partnership MUST happen before mid year.
As/ my many points posted. There are no other reasons for delays.
looking deeper than " just the facts" , are the timelines associated with each of those.
The Aware-1, bracelet , Pfizer " deal " is in ir near its 90day window.
A.N. In China is more or less ready to start phase 3 & waiting for Bracelet results as well.
The pancreatic cancer? That came out if the blue. Timelines? None have been given, other than they are waiting for longer data.
Car- t has been in discussions for over a year. No timelines were ever given on that.
So.,! .....IMHO, all of the existing data, studies, schedules point to June at the latest.
Some analysts say ( 2023), some say mid ( 2023).
why do I say MUST , by mid year?
By then there will be no more irons in the fire.
no more stones to overturn. 
Onc has made considerable scientific progress in 20+ years. The biomarker genome technology never existed, even 5 years ago.
I could go on, bottom line. Without valid clinical explanation, ONC is ready to progress with a partner.
 

<< Previous
Bullboard Posts
Next >>